VJHemOnc is committed to improving our service to you

EHA 2019 | Polyclonal immunoglobulin recovery as a myeloma survival predictor

VJHemOnc is committed to improving our service to you

Enrique Ocio

Enrique Ocio, MD, PhD, University Hospital of Salamanca, Salamanca, Spain, explains the recovery of polyclonal immunoglobulins as a predictive factor of increased progression-free survival and overall survival in patients with multiple myeloma that are ineligible for autologous stem-cell transplantation. This interview took place at the 24th Congress of the European Hematology Association (EHA) 2019, held in Amsterdam, Netherlands.

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter